Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Total	Series A Preferred Stock	Series B Preferred Stock	Preferred Stock Issued and Outstanding	Common Stock Issued and Outstanding	Common Stock Issued and Outstanding Series A Preferred Stock	Common Stock Issued and Outstanding Series B Preferred Stock	Additional Paid-In Capital	(Accumulated Deficit) Retained Earnings	Accumulated Other Comprehensive Loss
Preferred stock, beginning balance (in shares) at Dec. 31, 2022				4,000,000
Beginning balance at Dec. 31, 2022	$ 2,127			$ 0	$ 0			$ 2,558	$ (164)	$ (267)
Common stock, beginning balance (in shares) at Dec. 31, 2022					233,403,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	26								26
Fair value change - derivatives	(9)									(9)
Foreign currency translation adjustment	14									14
Gain on dedesignated derivatives amortized from AOCI into income	(4)									(4)
Preferred Stock dividend (in shares)							1,082,877
Share repurchases (in shares)					(541,316)
Share repurchases	(12)							(12)
Profit sharing plan contributions (in shares)					631,194
Profit sharing plan contributions	14							14
Share-based compensation and other, net (in shares)					636,233
Share-based compensation and other, net	9							9
Preferred stock, ending balance (in shares) at Mar. 31, 2023				4,000,000
Ending balance at Mar. 31, 2023	2,165			$ 0	$ 0			2,569	(138)	(266)
Common stock, ending balance (in shares) at Mar. 31, 2023					235,212,900
Preferred stock, beginning balance (in shares) at Dec. 31, 2022				4,000,000
Beginning balance at Dec. 31, 2022	2,127			$ 0	$ 0			2,558	(164)	(267)
Common stock, beginning balance (in shares) at Dec. 31, 2022					233,403,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	128
Fair value change - derivatives	7
Foreign currency translation adjustment	(22)
Preferred Stock dividend (in shares)			935,285
Preferred stock, ending balance (in shares) at Sep. 30, 2023				4,000,000
Ending balance at Sep. 30, 2023	2,232			$ 0	$ 0			2,562	(36)	(294)
Common stock, ending balance (in shares) at Sep. 30, 2023					235,146,035
Preferred stock, beginning balance (in shares) at Mar. 31, 2023				4,000,000
Beginning balance at Mar. 31, 2023	2,165			$ 0	$ 0			2,569	(138)	(266)
Common stock, beginning balance (in shares) at Mar. 31, 2023					235,212,900
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	48								48
Fair value change - derivatives	15									15
Foreign currency translation adjustment	27									27
Gain on dedesignated derivatives amortized from AOCI into income	(4)									(4)
Preferred Stock dividend (in shares)							436,992
Share repurchases (in shares)					(428,688)
Share repurchases	(11)							(11)
Share-based compensation and other, net (in shares)					49,201
Share-based compensation and other, net	7							7
Preferred stock, ending balance (in shares) at Jun. 30, 2023				4,000,000
Ending balance at Jun. 30, 2023	2,247			$ 0	$ 0			2,565	(90)	(228)
Common stock, ending balance (in shares) at Jun. 30, 2023					235,270,405
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	54								54
Fair value change - derivatives	1									1
Foreign currency translation adjustment	(63)									(63)
Gain on dedesignated derivatives amortized from AOCI into income	(4)									(4)
Preferred Stock dividend (in shares)			413,135
Share repurchases (in shares)					(656,489)
Share repurchases	(18)							(18)
Share-based compensation and other, net (in shares)					532,119
Share-based compensation and other, net	15							15
Preferred stock, ending balance (in shares) at Sep. 30, 2023				4,000,000
Ending balance at Sep. 30, 2023	2,232			$ 0	$ 0			2,562	(36)	(294)
Common stock, ending balance (in shares) at Sep. 30, 2023					235,146,035
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred Stock dividend (in shares)			337,044
Preferred stock, ending balance (in shares) at Dec. 31, 2023		4,000,000	800,000	4,000,000
Ending balance at Dec. 31, 2023	2,071			$ 0	$ 0			2,572	(11)	(490)
Common stock, ending balance (in shares) at Dec. 31, 2023					235,575,316
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	45								45
Fair value change - derivatives	13									13
Foreign currency translation adjustment	(42)									(42)
Gain on dedesignated derivatives amortized from AOCI into income	(4)									(4)
Preferred Stock dividend (in shares)						7,944,104	620,240
Series B Preferred Stock dividend	0							7	(7)
Conversion of Series B Preferred Stock, net (in shares)					16,260,163
Conversion of Series B Preferred Stock, net	197							214	(17)
Profit sharing plan contributions (in shares)					510,319
Profit sharing plan contributions	18							18
Share-based compensation and other, net (in shares)					726,809
Share-based compensation and other, net	3							3
Preferred stock, ending balance (in shares) at Mar. 31, 2024				4,000,000
Ending balance at Mar. 31, 2024	2,301			$ 0	$ 0			2,814	10	(523)
Common stock, ending balance (in shares) at Mar. 31, 2024					261,636,951
Preferred stock, beginning balance (in shares) at Dec. 31, 2023		4,000,000	800,000	4,000,000
Beginning balance at Dec. 31, 2023	2,071			$ 0	$ 0			2,572	(11)	(490)
Common stock, beginning balance (in shares) at Dec. 31, 2023					235,575,316
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	183
Fair value change - derivatives	(5)
Foreign currency translation adjustment	26
Preferred Stock dividend (in shares)			283,196
Preferred stock, ending balance (in shares) at Sep. 30, 2024		4,000,000	0	4,000,000
Ending balance at Sep. 30, 2024	2,967			$ 0	$ 0			3,300	148	(481)
Common stock, ending balance (in shares) at Sep. 30, 2024					274,761,552
Preferred stock, beginning balance (in shares) at Mar. 31, 2024				4,000,000
Beginning balance at Mar. 31, 2024	2,301			$ 0	$ 0			2,814	10	(523)
Common stock, beginning balance (in shares) at Mar. 31, 2024					261,636,951
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	69								69
Fair value change - derivatives	4									4
Foreign currency translation adjustment	(1)									(1)
Gain on dedesignated derivatives amortized from AOCI into income	(4)									(4)
Issuance of common shares (in shares)					12,650,000
Issuance of common shares	458							458
Share-based compensation and other, net (in shares)					32,702
Share-based compensation and other, net	8							8
Preferred stock, ending balance (in shares) at Jun. 30, 2024				4,000,000
Ending balance at Jun. 30, 2024	2,835			$ 0	$ 0			3,280	79	(524)
Common stock, ending balance (in shares) at Jun. 30, 2024					274,319,653
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	69								69
Fair value change - derivatives	(22)									(22)
Foreign currency translation adjustment	69									69
Gain on dedesignated derivatives amortized from AOCI into income	(4)									(4)
Share-based compensation and other, net (in shares)					441,899
Share-based compensation and other, net	20							20
Preferred stock, ending balance (in shares) at Sep. 30, 2024		4,000,000	0	4,000,000
Ending balance at Sep. 30, 2024	$ 2,967			$ 0	$ 0			$ 3,300	$ 148	$ (481)
Common stock, ending balance (in shares) at Sep. 30, 2024					274,761,552